SE451669C - Kompress innehaallande zinkoxid - Google Patents
Kompress innehaallande zinkoxidInfo
- Publication number
- SE451669C SE451669C SE8400855A SE8400855A SE451669C SE 451669 C SE451669 C SE 451669C SE 8400855 A SE8400855 A SE 8400855A SE 8400855 A SE8400855 A SE 8400855A SE 451669 C SE451669 C SE 451669C
- Authority
- SE
- Sweden
- Prior art keywords
- congress
- zinc oxide
- compress
- zinc
- requirements
- Prior art date
Links
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 title claims abstract description 85
- 239000011787 zinc oxide Substances 0.000 title claims abstract description 40
- 230000035876 healing Effects 0.000 claims abstract description 11
- 239000000654 additive Substances 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 229940088710 antibiotic agent Drugs 0.000 claims description 2
- 239000011630 iodine Substances 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims 2
- 241001181114 Neta Species 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 235000015067 sauces Nutrition 0.000 claims 1
- 230000000304 vasodilatating effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 5
- 229920000642 polymer Polymers 0.000 abstract description 4
- 230000004936 stimulating effect Effects 0.000 abstract description 2
- 239000011701 zinc Substances 0.000 description 41
- 206010052428 Wound Diseases 0.000 description 37
- 208000027418 Wounds and injury Diseases 0.000 description 36
- 229910052725 zinc Inorganic materials 0.000 description 34
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 32
- 238000011282 treatment Methods 0.000 description 19
- 230000000694 effects Effects 0.000 description 14
- 239000000725 suspension Substances 0.000 description 9
- 239000000835 fiber Substances 0.000 description 7
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 7
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 230000029663 wound healing Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 108010086613 Streptodornase and Streptokinase Proteins 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000000902 placebo Substances 0.000 description 5
- 229940068196 placebo Drugs 0.000 description 5
- 108091005804 Peptidases Proteins 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 230000001338 necrotic effect Effects 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 3
- 210000003630 histaminocyte Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010028851 Necrosis Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 206010048629 Wound secretion Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 210000003934 vacuole Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000005230 Leg Ulcer Diseases 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 210000000224 granular leucocyte Anatomy 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000013101 initial test Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000003947 neutron activation analysis Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- FGVVTMRZYROCTH-UHFFFAOYSA-N pyridine-2-thiol N-oxide Chemical compound [O-][N+]1=CC=CC=C1S FGVVTMRZYROCTH-UHFFFAOYSA-N 0.000 description 1
- 229960002026 pyrithione Drugs 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012882 sequential analysis Methods 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00987—Apparatus or processes for manufacturing non-adhesive dressings or bandages
- A61F13/00991—Apparatus or processes for manufacturing non-adhesive dressings or bandages for treating webs, e.g. for moisturising, coating, impregnating or applying powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/84—Accessories, not otherwise provided for, for absorbent pads
- A61F13/8405—Additives, e.g. for odour, disinfectant or pH control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00157—Wound bandages for burns or skin transplants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00519—Plasters use for treating burn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/0091—Plasters containing means with disinfecting or anaesthetics means, e.g. anti-mycrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/15577—Apparatus or processes for manufacturing
- A61F2013/15821—Apparatus or processes for manufacturing characterized by the apparatus for manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
- A61L2300/214—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Vascular Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Materials Engineering (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Manufacturing & Machinery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Press Drives And Press Lines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Jellies, Jams, And Syrups (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Detergent Compositions (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Medicinal Preparation (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Reduction Or Emphasis Of Bandwidth Of Signals (AREA)
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8400855A SE451669C (sv) | 1984-02-17 | 1984-02-17 | Kompress innehaallande zinkoxid |
| DE8585850053T DE3586569T2 (de) | 1984-02-17 | 1985-02-14 | Verband und verfahren zu seiner herstellung. |
| AT85850053T ATE80030T1 (de) | 1984-02-17 | 1985-02-14 | Verband und verfahren zu seiner herstellung. |
| EP85850053A EP0153915B1 (de) | 1984-02-17 | 1985-02-14 | Verband und Verfahren zu seiner Herstellung |
| DE198585850053T DE153915T1 (de) | 1984-02-17 | 1985-02-14 | Verband und verfahren zu seiner herstellung. |
| ES540447A ES8700570A1 (es) | 1984-02-17 | 1985-02-15 | Un metodo de preparar un vendaje |
| DK070785A DK160352C (da) | 1984-02-17 | 1985-02-15 | Kompres indeholdende zinkoxid |
| NO850605A NO162894C (no) | 1984-02-17 | 1985-02-15 | Fremgangsmaate til fremstilling av en kompress inneholdende middel for aa rense saar og stimulere til leging. |
| FI850649A FI85107C (fi) | 1984-02-17 | 1985-02-15 | Foerfarande foer framstaellning av en kompress. |
| CA000474372A CA1242973A (en) | 1984-02-17 | 1985-02-15 | Dressing and a method for the manufacture thereof |
| US06/703,130 US4685907A (en) | 1984-02-17 | 1985-02-19 | Dressing and a method for the manufacture thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8400855A SE451669C (sv) | 1984-02-17 | 1984-02-17 | Kompress innehaallande zinkoxid |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| SE8400855D0 SE8400855D0 (sv) | 1984-02-17 |
| SE8400855L SE8400855L (sv) | 1985-08-18 |
| SE451669B SE451669B (sv) | 1987-10-26 |
| SE451669C true SE451669C (sv) | 1989-08-14 |
Family
ID=20354776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8400855A SE451669C (sv) | 1984-02-17 | 1984-02-17 | Kompress innehaallande zinkoxid |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4685907A (de) |
| EP (1) | EP0153915B1 (de) |
| AT (1) | ATE80030T1 (de) |
| CA (1) | CA1242973A (de) |
| DE (2) | DE153915T1 (de) |
| DK (1) | DK160352C (de) |
| ES (1) | ES8700570A1 (de) |
| FI (1) | FI85107C (de) |
| NO (1) | NO162894C (de) |
| SE (1) | SE451669C (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2649318A1 (fr) * | 1989-07-07 | 1991-01-11 | Tisnes Paul | Formes galeniques deshydratees pour l'usage dermatologique et cosmetique |
| SE502495C2 (sv) * | 1990-04-24 | 1995-10-30 | Abigo Medical Ab | Antimikrobiellt, antiallergent och detoxifierande medel och användningen därav i hud- eller slemhinnebehandlingsprodukt, byggmaterial, papper och ytbehandlingsmaterial |
| US5415865A (en) * | 1990-04-24 | 1995-05-16 | Molnlycke Ab | Means having microbial effect and little or completely abolished tendency to develop contact allergic reactions or toxic effects and use thereof in e.g. skin and wound treatment products |
| EP0596215A1 (de) * | 1992-11-02 | 1994-05-11 | Sunfive Company Ltd | Material zur Verwendung als Schutz von Wundoberflächen |
| US5421291A (en) * | 1994-03-28 | 1995-06-06 | Church & Dwight Co., Inc. | Animal litter containing a water-swellable clay, carboxymethylcellulose, and siliceous coated bicarbonate particles |
| US6254294B1 (en) * | 1999-08-09 | 2001-07-03 | Sigrid G. Muhar | Pharmaceutical kit |
| GB9927648D0 (en) * | 1999-11-24 | 2000-01-19 | Boots Co Plc | Medicated dressings |
| US8367570B2 (en) * | 2002-04-04 | 2013-02-05 | The University Of Akron | Mechanically strong absorbent non-woven fibrous mats |
| ATE533516T1 (de) * | 2002-04-04 | 2011-12-15 | Univ Akron Akron Ohio | Nichtgewebte faserverbände |
| US11786455B2 (en) | 2011-05-10 | 2023-10-17 | Itochu Chemical Frontier Corporation | Non-aqueous patch |
| ES3034911T3 (en) | 2011-05-10 | 2025-08-26 | Itochu Chemical Frontier Corp | Non-aqueous patch |
| US9283174B2 (en) | 2011-05-10 | 2016-03-15 | Tatsuya Mori | Non-aqueous patch |
| US10765640B2 (en) | 2011-09-27 | 2020-09-08 | Itochu Chemical Frontier Corporation | Non-aqueous patch |
| DE102020207985A1 (de) | 2020-06-28 | 2021-12-30 | Innomotion AG | Sterile Vorrichtung zur Bedeckung der menschlichen Haut und Verfahren zur Herstellung einer sterilen Vorrichtung |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2063218A (en) * | 1932-07-26 | 1936-12-08 | Zisserman Leon | Antiseptic or medicated dressing or material and the manufacture thereof |
| DE1282228B (de) * | 1959-03-23 | 1968-11-07 | William M Scholl Dr | Streichmasse fuer die Herstellung von Gipsbinden |
| AT312810B (de) * | 1971-05-06 | 1974-01-25 | Bunzl & Biach Ag | Verbandstoff und Verfahren zu dessen Herstellung |
| US3872862A (en) * | 1973-10-23 | 1975-03-25 | Michael Hume | Dressing and support combination for the treatment of indolent ulcers |
| US4049802A (en) * | 1975-03-19 | 1977-09-20 | Research Corporation | Zinc sulfadiazine and its use in the treatment of burns |
| US4307717A (en) * | 1977-11-07 | 1981-12-29 | Lectec Corporation | Sterile improved bandage containing a medicament |
| SE425350B (sv) * | 1978-04-03 | 1982-09-27 | Moelnlycke Ab | Steril kompress for behandling av vetskande sar innehallande salt i fast form |
| US4214582A (en) * | 1979-02-07 | 1980-07-29 | The Kendall Company | Surgical dressing |
| US4401651A (en) * | 1979-04-18 | 1983-08-30 | Knutson Richard A | Wound-healing compositions containing povidone-iodine |
| US4310509A (en) * | 1979-07-31 | 1982-01-12 | Minnesota Mining And Manufacturing Company | Pressure-sensitive adhesive having a broad spectrum antimicrobial therein |
| DE3018969A1 (de) * | 1980-05-17 | 1981-11-26 | Beiersdorf Ag, 2000 Hamburg | Mischung fuer halbstarre medizinische stuetzverbaende, damit erhaltene medizinische binde und verfahren zu deren herstellung |
| DE3033606A1 (de) * | 1980-09-06 | 1982-04-08 | B. Braun Melsungen Ag, 3508 Melsungen | Antiadhaesiver, antimikrobieller wundverband und verfahren zu dessen herstellung |
-
1984
- 1984-02-17 SE SE8400855A patent/SE451669C/sv not_active IP Right Cessation
-
1985
- 1985-02-14 DE DE198585850053T patent/DE153915T1/de active Pending
- 1985-02-14 EP EP85850053A patent/EP0153915B1/de not_active Expired
- 1985-02-14 AT AT85850053T patent/ATE80030T1/de not_active IP Right Cessation
- 1985-02-14 DE DE8585850053T patent/DE3586569T2/de not_active Expired - Lifetime
- 1985-02-15 CA CA000474372A patent/CA1242973A/en not_active Expired
- 1985-02-15 ES ES540447A patent/ES8700570A1/es not_active Expired
- 1985-02-15 FI FI850649A patent/FI85107C/fi not_active IP Right Cessation
- 1985-02-15 NO NO850605A patent/NO162894C/no not_active IP Right Cessation
- 1985-02-15 DK DK070785A patent/DK160352C/da not_active IP Right Cessation
- 1985-02-19 US US06/703,130 patent/US4685907A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA1242973A (en) | 1988-10-11 |
| FI85107B (fi) | 1991-11-29 |
| FI850649A0 (fi) | 1985-02-15 |
| NO162894B (no) | 1989-11-27 |
| EP0153915A2 (de) | 1985-09-04 |
| NO162894C (no) | 1990-03-07 |
| DE153915T1 (de) | 1986-01-02 |
| FI850649L (fi) | 1985-08-18 |
| NO850605L (no) | 1985-08-19 |
| ES8700570A1 (es) | 1986-10-16 |
| SE451669B (sv) | 1987-10-26 |
| DK70785A (da) | 1985-08-18 |
| ES540447A0 (es) | 1986-10-16 |
| EP0153915B1 (de) | 1992-09-02 |
| SE8400855L (sv) | 1985-08-18 |
| SE8400855D0 (sv) | 1984-02-17 |
| ATE80030T1 (de) | 1992-09-15 |
| US4685907A (en) | 1987-08-11 |
| DK70785D0 (da) | 1985-02-15 |
| EP0153915A3 (en) | 1989-10-18 |
| DE3586569T2 (de) | 1993-02-04 |
| DK160352C (da) | 1991-08-12 |
| DK160352B (da) | 1991-03-04 |
| FI85107C (fi) | 1992-03-10 |
| DE3586569D1 (de) | 1992-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101360519B (zh) | 抗菌海藻酸盐制剂 | |
| Sarheed et al. | Antimicrobial dressings for improving wound healing | |
| EP2217287B1 (de) | Hygiene- oder pflegeartikel, aufweisend einen anteil an hydroaktiven polymeren, und eine zubereitung aufweisend bakteriophagen oder mindestens einen bestandteil derselben | |
| SE451669B (sv) | Kompress innehallande zinkoxid | |
| US9011901B2 (en) | Method of promoting hemostasis by using a dressing comprising extract of chamomile and nettle | |
| JP2015512403A5 (de) | ||
| Fang et al. | Development of a chitosan–vaseline gauze dressing with wound-healing properties in murine models | |
| JPH06508287A (ja) | 接着剤組成物および製品 | |
| CN114364379B (zh) | 含有金属有机框架材料的用于伤口愈合的组合物 | |
| CN103025386A (zh) | 用于治疗微生物感染的罗望子种子多糖 | |
| EP2051719B1 (de) | Zubereitung mit marinem kollagen zur proteinasehemmung | |
| CN110721334A (zh) | 一种止血创伤敷料及其制备方法 | |
| JP2005501016A (ja) | 抗菌性材料 | |
| Ali | Enhancement of Wound Healing in Rabbits Using Chitosan Nonwoven Sheets: A Comparative Study of Efficacy and Tissue Response | |
| RU2163147C1 (ru) | Способ изготовления кровоостанавливающего пластыря | |
| CN114533836B (zh) | 一种不影响bFGF活性的制剂及其制备方法和应用 | |
| RU2846026C1 (ru) | Применение водных растворов неполной двойной литиево-медной соли полиакриловой кислоты | |
| EP3318270A1 (de) | Stathminzusammensetzung und verfahren zur wundbehandlung | |
| Ali | The use of Propolis Nonwoven Material (NMS) Sheets to Enhance Wound Healing in Rabbits: A Macroscopic and Histopathological Evaluation | |
| RU2308960C1 (ru) | Ранозаживляющая губка | |
| Ahmed | Developing a single dressing containing both antifungal and antibacterial drugs for treating mixed infections in diabetic foot ulcers | |
| JPWO2015098864A1 (ja) | サルファ剤およびキトサン剤を含み、剤型が散剤である、ゲル形成剤 | |
| UA110923C2 (uk) | Гідрогелева композиція, спосіб її одержання та перев'язувальний засіб з її вмістом для лікування ран різної етіології |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8400855-6 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |